Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
15
Number of overlapping holdings
30.0%
% of FTXH's 51 holdings also in XPH
35.7%
% of XPH's 42 holdings also in FTXH
Overlap by Weight
Sector Drift (FTXH minus XPH)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FTXH |
Weight in XPH |
Overlap | |
|---|---|---|---|---|
 |
BRISTOL-MYERS SQUIBB CO | 8.7% | 4.3% | 4.3% |
|
VIATRIS, INC. | 4.1% | 4.1% | 4.1% |
|
ZOETIS INC | 3.8% | 3.5% | 3.5% |
 |
JAZZ PHARMACEUTICALS PLC | 3.5% | 4.3% | 3.5% |
|
JOHNSON & JOHNSON | 6.9% | 3.3% | 3.3% |
Position Highlights (Non-Overlapping Exposures)
FTXH Overweight Relative to XPH
|
ABBVIE INC | 6.9% |
|
GILEAD SCIENCES INC | 4.5% |
|
BRISTOL-MYERS SQUIBB CO | 4.4% |
|
CARDINAL HEALTH INC | 4.1% |
|
UNITED THERAPEUTICS CORP | 3.7% |
|
PFIZER INC | 3.5% |
|
JOHNSON & JOHNSON | 3.5% |
|
MERCK & CO. INC. | 3.4% |
|
AMGEN INC | 3.1% |
|
BIOGEN IDEC INC | 2.8% |
FTXH Underweight Relative to XPH
|
CORCEPT THERAPEUTICS INC | -4.7% |
|
CATALENT INC | -4.0% |
|
AXSOME THERAPEUTICS, INC. | -3.6% |
|
INTRA-CELLULAR THERAPIES INC | -3.6% |
|
TARSUS PHARMACEUTICALS, INC. | -3.5% |
|
ROYALTY PHARMA PLC CLASS A | -3.4% |
|
EDGEWISE THERAPEUTICS, INC. | -3.2% |
|
PERRIGO CO | -2.7% |
|
PACIRA PHARMACEUTICALS INC | -2.5% |
|
SUPERNUS PHARMACEUTICALS INC | -2.4% |